@hemehub.bsky.social
HemeHub (formerly BMFCases) | Supporting hematology by enhancing care, driving innovation, and advancing research & treatment strategies.
https://www.hemehub.org
https://www.hemehub.org
Today’s question focuses on the type of viral vector most commonly used in gene therapy trials for Hemophilia A.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials
November 21, 2025 at 10:28 PM
Today’s question focuses on the type of viral vector most commonly used in gene therapy trials for Hemophilia A.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials
Facts about Hemophilia A: Treatment — Factor Replacement Era
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials #BloodDisorders @thjournal.bsky.social @htrstoday.bsky.social @sfthemostase.bsky.social @ash.edu.hematology.org
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials #BloodDisorders @thjournal.bsky.social @htrstoday.bsky.social @sfthemostase.bsky.social @ash.edu.hematology.org
November 21, 2025 at 10:28 PM
Facts about Hemophilia A: Treatment — Factor Replacement Era
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials #BloodDisorders @thjournal.bsky.social @htrstoday.bsky.social @sfthemostase.bsky.social @ash.edu.hematology.org
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials #BloodDisorders @thjournal.bsky.social @htrstoday.bsky.social @sfthemostase.bsky.social @ash.edu.hematology.org
Today’s question focuses on safe management of breakthrough bleeding in a patient receiving emicizumab prophylaxis.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials
November 20, 2025 at 8:37 PM
Today’s question focuses on safe management of breakthrough bleeding in a patient receiving emicizumab prophylaxis.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials
Facts about Hemophilia A:
Additional information on diagnosis and screening
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials #BloodDisorders @htrstoday.bsky.social @sfthemostase.bsky.social @thjournal.bsky.social
Additional information on diagnosis and screening
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials #BloodDisorders @htrstoday.bsky.social @sfthemostase.bsky.social @thjournal.bsky.social
November 20, 2025 at 8:36 PM
Facts about Hemophilia A:
Additional information on diagnosis and screening
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials #BloodDisorders @htrstoday.bsky.social @sfthemostase.bsky.social @thjournal.bsky.social
Additional information on diagnosis and screening
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials #BloodDisorders @htrstoday.bsky.social @sfthemostase.bsky.social @thjournal.bsky.social
Today’s question focuses on the expected laboratory pattern in a child with Hemophilia A who presents with bleeding after missing a prophylactic infusion.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy
November 17, 2025 at 11:13 PM
Today’s question focuses on the expected laboratory pattern in a child with Hemophilia A who presents with bleeding after missing a prophylactic infusion.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy
Facts about Hemophilia A: Diagnosis and Screening
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials #BloodDisorders @thjournal.bsky.social @htrstoday.bsky.social @sfthemostase.bsky.social @ash.edu.hematology.org
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials #BloodDisorders @thjournal.bsky.social @htrstoday.bsky.social @sfthemostase.bsky.social @ash.edu.hematology.org
November 17, 2025 at 11:10 PM
Facts about Hemophilia A: Diagnosis and Screening
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials #BloodDisorders @thjournal.bsky.social @htrstoday.bsky.social @sfthemostase.bsky.social @ash.edu.hematology.org
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials #BloodDisorders @thjournal.bsky.social @htrstoday.bsky.social @sfthemostase.bsky.social @ash.edu.hematology.org
Today’s question focuses on hemostatic management before a dental procedure in a patient with mild Hemophilia A.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy
November 16, 2025 at 12:25 AM
Today’s question focuses on hemostatic management before a dental procedure in a patient with mild Hemophilia A.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy
Facts about Hemophilia A: Clinical Manifestations
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy @thjournal.bsky.social @athnnews.bsky.social @htrstoday.bsky.social @sfthemostase.bsky.social @ash.edu.hematology.org
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy @thjournal.bsky.social @athnnews.bsky.social @htrstoday.bsky.social @sfthemostase.bsky.social @ash.edu.hematology.org
November 16, 2025 at 12:24 AM
Facts about Hemophilia A: Clinical Manifestations
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy @thjournal.bsky.social @athnnews.bsky.social @htrstoday.bsky.social @sfthemostase.bsky.social @ash.edu.hematology.org
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy @thjournal.bsky.social @athnnews.bsky.social @htrstoday.bsky.social @sfthemostase.bsky.social @ash.edu.hematology.org
Today’s question highlights the first diagnostic step in evaluating a newborn with suspected Hemophilia A.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #InternalMedicine #ClinicalTrials #BloodDisorders
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #InternalMedicine #ClinicalTrials #BloodDisorders
November 13, 2025 at 8:06 PM
Today’s question highlights the first diagnostic step in evaluating a newborn with suspected Hemophilia A.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #InternalMedicine #ClinicalTrials #BloodDisorders
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #InternalMedicine #ClinicalTrials #BloodDisorders
Facts about Hemophilia A: Clinical Manifestations
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials #BloodDisorders @htrstoday.bsky.social @thjournal.bsky.social @sfthemostase.bsky.social @athnnews.bsky.social
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials #BloodDisorders @htrstoday.bsky.social @thjournal.bsky.social @sfthemostase.bsky.social @athnnews.bsky.social
November 13, 2025 at 8:05 PM
Facts about Hemophilia A: Clinical Manifestations
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials #BloodDisorders @htrstoday.bsky.social @thjournal.bsky.social @sfthemostase.bsky.social @athnnews.bsky.social
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials #BloodDisorders @htrstoday.bsky.social @thjournal.bsky.social @sfthemostase.bsky.social @athnnews.bsky.social
Today’s question highlights the cytokine responsible for joint damage in Hemophilia A.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials #BloodDisorders
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials #BloodDisorders
November 12, 2025 at 2:08 AM
Today’s question highlights the cytokine responsible for joint damage in Hemophilia A.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials #BloodDisorders
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #Emicizumab #InternalMedicine #ClinicalTrials #BloodDisorders
Today’s question focuses on bleed management in a young patient with severe Hemophilia A who has developed an inhibitor.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #ClinicalTrials #BloodDisorders
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #ClinicalTrials #BloodDisorders
November 10, 2025 at 9:51 PM
Today’s question focuses on bleed management in a young patient with severe Hemophilia A who has developed an inhibitor.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #ClinicalTrials #BloodDisorders
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #ClinicalTrials #BloodDisorders
Facts about Hemophilia A: Molecular Genetics and Pathogenesis
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy @ash.edu.hematology.org @ash.hematology.org @htrstoday.bsky.social @thjournal.bsky.social @athnnews.bsky.social @isth.org @jthjournal.bsky.social
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy @ash.edu.hematology.org @ash.hematology.org @htrstoday.bsky.social @thjournal.bsky.social @athnnews.bsky.social @isth.org @jthjournal.bsky.social
November 10, 2025 at 9:49 PM
Facts about Hemophilia A: Molecular Genetics and Pathogenesis
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy @ash.edu.hematology.org @ash.hematology.org @htrstoday.bsky.social @thjournal.bsky.social @athnnews.bsky.social @isth.org @jthjournal.bsky.social
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy @ash.edu.hematology.org @ash.hematology.org @htrstoday.bsky.social @thjournal.bsky.social @athnnews.bsky.social @isth.org @jthjournal.bsky.social
Today’s question highlights how to approach a new bleed and prolonged aPTT in a patient on prophylaxis for Hemophilia A.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #ClinicalTrials #BloodDisorders
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #ClinicalTrials #BloodDisorders
November 8, 2025 at 10:36 PM
Today’s question highlights how to approach a new bleed and prolonged aPTT in a patient on prophylaxis for Hemophilia A.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #ClinicalTrials #BloodDisorders
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #ClinicalTrials #BloodDisorders
Facts about Hemophilia A: Molecular Genetics and Pathogenesis
Key genetic mutations in the factor 8 gene determine disease severity, with intron inversions linked to severe cases and missense mutations causing milder forms.
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation
Key genetic mutations in the factor 8 gene determine disease severity, with intron inversions linked to severe cases and missense mutations causing milder forms.
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation
November 8, 2025 at 10:35 PM
Facts about Hemophilia A: Molecular Genetics and Pathogenesis
Key genetic mutations in the factor 8 gene determine disease severity, with intron inversions linked to severe cases and missense mutations causing milder forms.
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation
Key genetic mutations in the factor 8 gene determine disease severity, with intron inversions linked to severe cases and missense mutations causing milder forms.
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation
🧬 Today’s question focuses on prophylactic options for a young patient with severe Hemophilia A and considerations for administration route.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #InternalMedicine #ClinicalTrials
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #InternalMedicine #ClinicalTrials
November 6, 2025 at 9:46 PM
🧬 Today’s question focuses on prophylactic options for a young patient with severe Hemophilia A and considerations for administration route.
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #InternalMedicine #ClinicalTrials
See the answer and explanation on the next slide!
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation #InternalMedicine #ClinicalTrials
Facts about Hemophilia A: Disease Overview and Epidemiology
Advances in screening, data reporting, and prophylaxis have transformed outcomes in high-income countries, while access gaps persist in resource-limited countries.
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation
Advances in screening, data reporting, and prophylaxis have transformed outcomes in high-income countries, while access gaps persist in resource-limited countries.
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation
November 6, 2025 at 9:44 PM
Facts about Hemophilia A: Disease Overview and Epidemiology
Advances in screening, data reporting, and prophylaxis have transformed outcomes in high-income countries, while access gaps persist in resource-limited countries.
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation
Advances in screening, data reporting, and prophylaxis have transformed outcomes in high-income countries, while access gaps persist in resource-limited countries.
#Hemophilia #BleedingDisorders #Hematology #RareDiseases #Coagulation
🧬Today's question examines how coagulation studies help differentiate causes of prolonged aPTT in a child with recurrent bleeding.
See the answer and explanation on the next slide!
#HemophiliaA #FactorVIII #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #InternalMedicine
See the answer and explanation on the next slide!
#HemophiliaA #FactorVIII #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #InternalMedicine
November 6, 2025 at 1:12 AM
🧬Today's question examines how coagulation studies help differentiate causes of prolonged aPTT in a child with recurrent bleeding.
See the answer and explanation on the next slide!
#HemophiliaA #FactorVIII #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #InternalMedicine
See the answer and explanation on the next slide!
#HemophiliaA #FactorVIII #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #InternalMedicine
Facts about Hemophilia A:
A concise overview of the mechanisms that link F8 gene mutations to clinical phenotype and disease severity.
#HemophiliaA #FactorVIII #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #ClinicalTrials #TranslationalMedicine #BloodDisorders
A concise overview of the mechanisms that link F8 gene mutations to clinical phenotype and disease severity.
#HemophiliaA #FactorVIII #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #ClinicalTrials #TranslationalMedicine #BloodDisorders
November 6, 2025 at 1:11 AM
Facts about Hemophilia A:
A concise overview of the mechanisms that link F8 gene mutations to clinical phenotype and disease severity.
#HemophiliaA #FactorVIII #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #ClinicalTrials #TranslationalMedicine #BloodDisorders
A concise overview of the mechanisms that link F8 gene mutations to clinical phenotype and disease severity.
#HemophiliaA #FactorVIII #BleedingDisorders #Hematology #RareDiseases #Coagulation #GeneTherapy #ClinicalTrials #TranslationalMedicine #BloodDisorders
🩸This Month on HemeHub: Hemophilia A
Join us as we explore advances in the understanding and management of Hemophilia A, including strategies to improve patient outcomes and care. Stay tuned for our upcoming session featuring Dr. Shannon Meeks!
#HemophiliaA #Hematology #RareDiseases
Join us as we explore advances in the understanding and management of Hemophilia A, including strategies to improve patient outcomes and care. Stay tuned for our upcoming session featuring Dr. Shannon Meeks!
#HemophiliaA #Hematology #RareDiseases
November 5, 2025 at 12:41 AM
🩸This Month on HemeHub: Hemophilia A
Join us as we explore advances in the understanding and management of Hemophilia A, including strategies to improve patient outcomes and care. Stay tuned for our upcoming session featuring Dr. Shannon Meeks!
#HemophiliaA #Hematology #RareDiseases
Join us as we explore advances in the understanding and management of Hemophilia A, including strategies to improve patient outcomes and care. Stay tuned for our upcoming session featuring Dr. Shannon Meeks!
#HemophiliaA #Hematology #RareDiseases
🧬The second question of the day focuses on how patient-reported outcomes reflect clinical benefit after Casgevy therapy.
#Casgevy #GeneTherapy #CRISPRGeneEditing #SickleCellGeneTherapy #SickleCellDisease #Hematology #CellTherapy #TranslationalMedicine #ClinicalTrials #RareDiseases #BloodDisorders
#Casgevy #GeneTherapy #CRISPRGeneEditing #SickleCellGeneTherapy #SickleCellDisease #Hematology #CellTherapy #TranslationalMedicine #ClinicalTrials #RareDiseases #BloodDisorders
October 29, 2025 at 7:03 PM
🧬The second question of the day focuses on how patient-reported outcomes reflect clinical benefit after Casgevy therapy.
#Casgevy #GeneTherapy #CRISPRGeneEditing #SickleCellGeneTherapy #SickleCellDisease #Hematology #CellTherapy #TranslationalMedicine #ClinicalTrials #RareDiseases #BloodDisorders
#Casgevy #GeneTherapy #CRISPRGeneEditing #SickleCellGeneTherapy #SickleCellDisease #Hematology #CellTherapy #TranslationalMedicine #ClinicalTrials #RareDiseases #BloodDisorders
🧬 Today’s first question focuses on interpreting hemoglobin expression patterns following Casgevy treatment.
See the answer and explanation on the next slide!
#Casgevy #GeneTherapy #CRISPRGeneEditing #SickleCellDisease #Hematology #CellTherapy #TranslationalMedicine #ClinicalTrials #RareDiseases
See the answer and explanation on the next slide!
#Casgevy #GeneTherapy #CRISPRGeneEditing #SickleCellDisease #Hematology #CellTherapy #TranslationalMedicine #ClinicalTrials #RareDiseases
October 29, 2025 at 7:02 PM
🧬 Today’s first question focuses on interpreting hemoglobin expression patterns following Casgevy treatment.
See the answer and explanation on the next slide!
#Casgevy #GeneTherapy #CRISPRGeneEditing #SickleCellDisease #Hematology #CellTherapy #TranslationalMedicine #ClinicalTrials #RareDiseases
See the answer and explanation on the next slide!
#Casgevy #GeneTherapy #CRISPRGeneEditing #SickleCellDisease #Hematology #CellTherapy #TranslationalMedicine #ClinicalTrials #RareDiseases
General Facts about Gene Therapy:
#LentiGlobin and #Exa-cel studies
#Casgevy #Lyfgenia #GeneTherapy #CRISPR #SickleCellDisease #Hematology #CellTherapy #ClinicalTrials
@ash.edu.hematology.org @asgct.bsky.social @cfgtedinburgh.bsky.social @genesndiseases.bsky.social
@bsochaem.bsky.social
#LentiGlobin and #Exa-cel studies
#Casgevy #Lyfgenia #GeneTherapy #CRISPR #SickleCellDisease #Hematology #CellTherapy #ClinicalTrials
@ash.edu.hematology.org @asgct.bsky.social @cfgtedinburgh.bsky.social @genesndiseases.bsky.social
@bsochaem.bsky.social
October 29, 2025 at 7:01 PM
General Facts about Gene Therapy:
#LentiGlobin and #Exa-cel studies
#Casgevy #Lyfgenia #GeneTherapy #CRISPR #SickleCellDisease #Hematology #CellTherapy #ClinicalTrials
@ash.edu.hematology.org @asgct.bsky.social @cfgtedinburgh.bsky.social @genesndiseases.bsky.social
@bsochaem.bsky.social
#LentiGlobin and #Exa-cel studies
#Casgevy #Lyfgenia #GeneTherapy #CRISPR #SickleCellDisease #Hematology #CellTherapy #ClinicalTrials
@ash.edu.hematology.org @asgct.bsky.social @cfgtedinburgh.bsky.social @genesndiseases.bsky.social
@bsochaem.bsky.social
🩸Join us for a special session with Dr. Shannon Meeks to explore advances in hemophilia A research!
🔗Register now: hemehub.org/live-events
#HemophiliaA #Hemostasis #BloodDisorders #Hematology #ClinicalTrials @isth.org @thjournal.bsky.social @ash.edu.hematology.org @cuhemeonc.bsky.social
🔗Register now: hemehub.org/live-events
#HemophiliaA #Hemostasis #BloodDisorders #Hematology #ClinicalTrials @isth.org @thjournal.bsky.social @ash.edu.hematology.org @cuhemeonc.bsky.social
October 29, 2025 at 12:09 AM
🩸Join us for a special session with Dr. Shannon Meeks to explore advances in hemophilia A research!
🔗Register now: hemehub.org/live-events
#HemophiliaA #Hemostasis #BloodDisorders #Hematology #ClinicalTrials @isth.org @thjournal.bsky.social @ash.edu.hematology.org @cuhemeonc.bsky.social
🔗Register now: hemehub.org/live-events
#HemophiliaA #Hemostasis #BloodDisorders #Hematology #ClinicalTrials @isth.org @thjournal.bsky.social @ash.edu.hematology.org @cuhemeonc.bsky.social
🧬 Today's second question highlights the significance of neutrophil engraftment timing in #Casgevy studies.
See the answer and explanation on the next slide!
#GeneTherapy #SickleCellDisease #Hematology #CellTherapy #TranslationalMedicine #ClinicalTrials #RareDiseases #BloodDisorders #StemCells
See the answer and explanation on the next slide!
#GeneTherapy #SickleCellDisease #Hematology #CellTherapy #TranslationalMedicine #ClinicalTrials #RareDiseases #BloodDisorders #StemCells
October 28, 2025 at 11:59 PM
🧬 Today's second question highlights the significance of neutrophil engraftment timing in #Casgevy studies.
See the answer and explanation on the next slide!
#GeneTherapy #SickleCellDisease #Hematology #CellTherapy #TranslationalMedicine #ClinicalTrials #RareDiseases #BloodDisorders #StemCells
See the answer and explanation on the next slide!
#GeneTherapy #SickleCellDisease #Hematology #CellTherapy #TranslationalMedicine #ClinicalTrials #RareDiseases #BloodDisorders #StemCells